Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
QDEL Quidel Corporation daily Stock Chart
QDEL [NASD]
Quidel Corporation
Healthcare | Diagnostic Substances | USA
financial highlights | statements
Index- P/E64.02 EPS (ttm)0.83 Insider Own1.30% Shs Outstand39.14M Perf Week9.04%
Market Cap2.09B Forward P/E18.28 EPS next Y2.92 Insider Trans-32.84% Shs Float34.39M Perf Month5.15%
Income36.60M PEG1.29 EPS next Q0.60 Inst Own91.20% Short Float7.30% Perf Quarter-16.28%
Sales504.60M P/S4.14 EPS this Y42.70% Inst Trans-0.01% Short Ratio9.07 Perf Half Y-23.38%
Book/sh9.89 P/B5.39 EPS next Y2.28% ROA4.40% Target Price68.20 Perf Year15.96%
Cash/sh0.99 P/C53.94 EPS next 5Y49.50% ROE11.10% 52W Range41.50 - 77.63 Perf YTD9.24%
Dividend- P/FCF27.18 EPS past 5Y-29.50% ROI1.50% 52W High-31.30% Beta1.19
Dividend %- Quick Ratio0.90 Sales past 5Y12.30% Gross Margin57.00% 52W Low28.51% ATR2.57
Employees1193 Current Ratio1.30 Sales Q/Q130.60% Oper. Margin12.70% RSI (14)54.34 Volatility3.76% 4.11%
OptionableYes Debt/Eq0.35 EPS Q/Q254.90% Profit Margin7.30% Rel Volume0.67 Prev Close51.96
ShortableYes LT Debt/Eq0.21 EarningsFeb 05 AMC Payout0.00% Avg Volume276.94K Price53.33
Recom1.90 SMA208.62% SMA50-4.73% SMA200-14.92% Volume185,855 Change2.64%
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Mar-03-11Downgrade Wedbush Outperform → Neutral $14 → $13
Nov-16-10Initiated Canaccord Genuity Buy $18
May-27-10Upgrade Wedbush Neutral → Outperform $15
Jan-11-19 12:55PM  7 Cheap Stocks to Buy on the Dip Kiplinger
Jan-09-19 10:01AM  How Much Did Quidel Corporations (NASDAQ:QDEL) CEO Pocket Last Year? Simply Wall St.
Jan-07-19 04:10PM  Quidel Announces Preliminary Revenue for Fourth Quarter 2018 Business Wire
Jan-02-19 05:30PM  Quidel to Present at 37th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-20-18 12:25PM  Hedge Funds Arent Crazy About Quidel Corporation (QDEL) Anymore Insider Monkey
Dec-19-18 06:00PM  Quidel Receives CE Mark for Its Point-of-Care Sofia® Quantitative Vitamin D Assay for Use With Sofia Instrument Business Wire
Dec-18-18 06:30PM  Quidel Receives CE Mark for Point-of-Care Sofia® 2 Lyme+ Fluorescent Immunoassay for Use with Sofia 2 Instrument Business Wire
Dec-17-18 09:05AM  Here's Why You Should Buy Express Scripts (ESRX) Stock Now Zacks
07:20AM  Analysis: Positioning to Benefit within Quidel, Granite Construction, FireEye, Consolidated Edison, EnPro Industries, and Blueprint Medicines Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Dec-14-18 06:43AM  Here's Why You Should Hold Allscripts Stock in Your Portfolio Zacks
Dec-13-18 05:00PM  Quidel Announces the Availability of Triage® PLGF Assay for Use with Quidels Triage® MeterPro Instrumented System Business Wire
02:23PM  Express Scripts Announces 3-Year Agreement With Walmart Zacks
Dec-12-18 08:58AM  Quidel (QDEL) Catches Eye: Stock Jumps 6.7% Zacks
08:16AM  BD Gets Enterprise Level Cybersecurity Assessment From UL Zacks
Dec-10-18 08:53AM  Here's Why Investors Should Hold Masimo (MASI) Stock Now Zacks
08:45AM  A Look At The Intrinsic Value Of Quidel Corporation (NASDAQ:QDEL) Simply Wall St.
Dec-07-18 07:31PM  Quidel to Hold BNP Supply Agreement Update Conference Call on December 10, 2018 Business Wire -20.53%
03:00PM  Quidel Comments on California Court Ruling Business Wire
Dec-06-18 08:44AM  Here's Why You Should Hold Pacific Biosciences (PACB) Now Zacks
Dec-04-18 09:33AM  Here's Why You Should Invest in Accuray (ARAY) Stock Now Zacks
Dec-03-18 06:57AM  Ecolab to Buy Bioquell for Healthcare & Life Sciences' Growth Zacks
Nov-29-18 09:27AM  Quidel Receives CE Mark for TriageTrueTM High Sensitivity Troponin I Test, Its Next-Generation Diagnostic Assay for Aid in Diagnosis of Myocardial Infarction for Use with Quidels Triage® MeterPro Instrumented System Business Wire
Nov-28-18 08:50AM  Cardinal Health to Highlight Cost-Control Approach in ASHP Zacks +6.85%
08:16AM  Zacks.com highlights: DexCom, E*TRADE Financial, MCBC Holdings and Quidel Zacks
Nov-27-18 09:02AM  Here's Why Investors Should Hold Medidata (MDSO) Stock Now Zacks
06:43AM  4 Profitable Stocks Boasting Amazingly High Net Income Ratio Zacks
Nov-19-18 05:00AM  Edited Transcript of QDEL earnings conference call or presentation 6-Nov-18 10:00pm GMT Thomson Reuters StreetEvents -5.16%
Nov-12-18 04:05PM  Quidel to Present at the 30th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-09-18 08:25AM  New Research Coverage Highlights Harmonic, ScanSource, Clean Energy Fuels, American Software, Diplomat Pharmacy, and Quidel Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-08-18 02:36PM  Did Quidel Corporation (NASDAQ:QDEL) Use Debt To Deliver Its ROE Of 9.9%? Simply Wall St.
Nov-06-18 07:15PM  Quidel (QDEL) Surpasses Q3 Earnings Estimates Zacks
06:15PM  Quidel: 3Q Earnings Snapshot Associated Press
04:10PM  Quidel Reports Third Quarter 2018 Financial Results Business Wire
Nov-02-18 09:42AM  What's in Store for Quidel (QDEL) This Earnings Season? Zacks
Oct-30-18 07:41AM  3 Medical Product Stocks to Trump Estimates in Q3 Earnings Zacks
Oct-29-18 10:02AM  Can BD Medical Drive Becton, Dickinson's (BDX) Q4 Earnings? Zacks
Oct-26-18 10:10AM  Why Quidel (QDEL) Could Beat Earnings Estimates Again Zacks
Oct-17-18 04:10PM  Quidel to Hold Third Quarter 2018 Financial Results Conference Call on November 6th, 2018 Business Wire
Oct-09-18 08:35AM  Research Report Identifies Keysight Technologies, Quidel, LKQ, Louisiana-Pacific, Air Transport Services Group, and Del Frisco's Restaurant Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Sep-24-18 11:43AM  Is Quidel Corporations (NASDAQ:QDEL) Liquidity Good Enough? Simply Wall St.
08:45AM  Are Options Traders Betting on a Big Move in Quidel (QDEL) Stock? Zacks
Sep-20-18 09:31AM  3 Top Stocks From the Booming US Medical Products Industry Zacks
Sep-18-18 06:41PM  Medical - Products Stock Outlook: Short-Term Pain Inevitable Zacks
Sep-05-18 10:21AM  Agios (AGIO) Assigns Ex-Celgene Executive to CEO Position Zacks
Aug-31-18 08:29AM  The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage Benzinga
Aug-30-18 06:40PM  Quidel Receives FDA Clearance, CLIA Waiver for Its Point-of-Care Sofia® 2 Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument from Finger-Stick Whole Blood Specimens Business Wire
Aug-20-18 05:45PM  Edited Transcript of QDEL earnings conference call or presentation 7-Aug-18 9:00pm GMT Thomson Reuters StreetEvents
Aug-16-18 09:00AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Aug-07-18 08:05PM  Quidel (QDEL) Surpasses Q2 Earnings and Revenue Estimates Zacks
06:59PM  Quidel: 2Q Earnings Snapshot Associated Press
04:10PM  Quidel Reports Second Quarter 2018 Financial Results Business Wire
Jul-31-18 08:00AM  New Research Coverage Highlights Federated Investors, SailPoint Technologies, Quidel, L3 Technologies, Pentair plc, and Veeva Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jul-17-18 04:10PM  Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018 Business Wire
Jul-16-18 01:00PM  Quidel Receives FDA Clearance for Solana® Bordetella Complete® Molecular Diagnostic Assay for the Detection of Pertussis (Whooping Cough), Parapertussis Infections Business Wire
Jun-22-18 02:17PM  Is Quidel Corporation (NASDAQ:QDEL) Worth US$069.58 Based On Intrinsic Value? Simply Wall St.
Jun-13-18 08:36AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Jun-05-18 04:10PM  Quidel to Present at William Blair 38th Annual Growth Stock Conference Business Wire
May-31-18 10:15PM  Quidel Announces Private Exchange Transactions Business Wire
May-16-18 10:10AM  Is SPDR S&P Health Care Equipment ETF (XHE) a Hot ETF Right Now? Zacks
May-15-18 05:00PM  Quidel to Present at UBS Global Healthcare Conference Business Wire
May-11-18 01:56AM  Edited Transcript of QDEL earnings conference call or presentation 8-May-18 9:00pm GMT Thomson Reuters StreetEvents
May-08-18 06:49PM  Quidel: 1Q Earnings Snapshot Associated Press
04:10PM  Quidel Reports First Quarter 2018 Financial Results Business Wire
Apr-23-18 04:10PM  Quidel to Hold First Quarter 2018 Financial Results Conference Call on May 8, 2018 Business Wire
Apr-18-18 07:40AM  New Research Coverage Highlights Quidel, Eros International, Hennessy Capital Acquisition Corp. II, United Dominion Realty Trust, Fidus Investment, and Kadant Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Apr-06-18 08:31AM  Is the Options Market Predicting a Spike in Quidel (QDEL) Stock? Zacks
Mar-29-18 08:15AM  New Research Coverage Highlights Digital Realty Trust, United Dominion Realty Trust, Quidel, Brandywine Realty Trust, Beneficial, and Coca-Cola Bottling Co. Consolidated Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-27-18 05:00PM  Quidel to Host 2018 Analyst and Investor Day in Chicago Business Wire
Mar-15-18 08:51AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Mar-08-18 07:00PM  Quidel Announces Private Exchange Transactions Business Wire
01:06PM  Near-Term Catalysts, Long-Term Opportunities Make Quidel A Strong Buy, Says Raymond James Benzinga
Mar-06-18 08:26AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
Mar-05-18 04:10PM  Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme Fluorescent Immunoassay for Use with Sofia® 2 Instrument Business Wire
Feb-26-18 05:30PM  Quidel to Present at Upcoming Conferences Business Wire
Feb-22-18 02:26PM  Edited Transcript of QDEL earnings conference call or presentation 21-Feb-18 10:00pm GMT Thomson Reuters StreetEvents -5.80%
Feb-21-18 07:19PM  Quidel reports 4Q loss Associated Press
04:10PM  Quidel Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
Feb-13-18 06:45PM  Quidel Receives 510(k) Clearance for QuickVue® Influenza A+B Test, Assay Meets FDAs Class II RIDT Requirements Business Wire
Feb-12-18 08:33AM  Options Traders Expect Huge Moves in Quidel (QDEL) Stock Zacks
Feb-07-18 06:16PM  Quidel to Hold Fourth Quarter and Full Year 2017 Financial Results Conference Call on February 21, 2018 Business Wire
Jan-26-18 07:55AM  Report: Developing Opportunities within Quidel, Earthstone Energy, Potbelly, Chemed, Great Southern, and Intel Future Expectations, Projections Moving into 2018 GlobeNewswire
Jan-19-18 08:30AM  Implied Volatility Surging for Quidel (QDEL) Stock Options Zacks
Jan-05-18 02:45PM  Quidel Completes Sale Leaseback of Summers Ridge Property for $148.65 Million Business Wire
Dec-21-17 06:50PM  Quidel Receives FDA Clearance and CLIA Waiver for Its Point-of-Care Sofia® 2 Instrument for Use with Sofia Strep A+ Assay Business Wire
06:45PM  Quidel Receives FDA Clearance for Its New Solana® Molecular Assay for the Detection of Group B Streptococcal Infections Business Wire
06:00PM  Quidel to Present at 36th Annual J.P. Morgan Healthcare Conference Business Wire
11:45AM  ETFs with exposure to Quidel Corp. : December 21, 2017 Capital Cube
Dec-19-17 05:37PM  Quidel Files Form 8-K/A, Reports Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses Business Wire
Dec-13-17 07:00PM  Quidel Announces Timing of Filing of Form 8-K/A To Report Historical and Pro Forma Financial Information for Acquired Triage Assets and Combined Quidel and Triage Businesses Business Wire
Dec-11-17 07:24AM  Quidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : December 11, 2017 Capital Cube
Nov-28-17 01:05PM  ETFs with exposure to Quidel Corp. : November 28, 2017 Capital Cube
Nov-27-17 04:13PM  Why Quidel Corporation Is Sinking Motley Fool -8.97%
12:40PM  Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets Business Wire
Nov-15-17 04:05PM  Quidel to Present at the 29th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-08-17 06:29PM  ETFs with exposure to Quidel Corp. : November 8, 2017 Capital Cube
Nov-07-17 08:06AM  Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Capital Cube
Nov-06-17 01:16PM  Quidel Corp. Value Analysis (NASDAQ:QDEL) : November 6, 2017 Capital Cube
Nov-03-17 08:35AM  Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017 Capital Cube
Nov-02-17 11:50AM  Edited Transcript of QDEL earnings conference call or presentation 1-Nov-17 9:00pm GMT Thomson Reuters StreetEvents
Nov-01-17 06:39PM  Quidel reports 3Q loss Associated Press
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye. It also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, the company offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, it provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, the company offers AmpliVue hand-held molecular diagnostic assay platform for the detection of the pathogen; Solana, an amplification and detection system; and Lyra molecular real-time polymerase chain reaction assays. The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, leading universities, retail clinics, pharmacies, and wellness screening centers. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
POLAN MARY LAKE PH DDirectorJan 04Option Exercise13.2514,449191,44929,628Jan 07 08:39 PM
STEWARD RANDALL JChief Financial OfficerDec 03Sale61.5115,000922,65316,790Dec 06 08:10 PM
BRYANT DOUGLAS CPresident & CEONov 28Option Exercise13.8618,033250,009312,346Nov 30 08:10 PM
BRYANT DOUGLAS CPresident & CEONov 28Sale61.1718,0331,103,079294,313Nov 30 08:10 PM
BRYANT DOUGLAS CPresident & CEOOct 31Option Exercise12.367,21789,202301,530Nov 02 08:02 PM
BRYANT DOUGLAS CPresident & CEOOct 31Sale65.107,217469,827294,313Nov 02 08:02 PM
BRYANT DOUGLAS CPresident & CEOSep 28Option Exercise12.3625,250312,090319,563Oct 01 08:10 PM
BRYANT DOUGLAS CPresident & CEOSep 28Sale65.1925,2501,646,048294,313Oct 01 08:10 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsSep 11Option Exercise17.1113,000222,41021,887Sep 13 08:05 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsSep 11Sale72.2913,000939,7328,887Sep 13 08:05 PM
BUECHLER KENNETH FDirectorAug 30Option Exercise11.965,00059,80053,519Sep 04 08:03 PM
BUECHLER KENNETH FDirectorAug 30Sale75.015,000375,03948,519Sep 04 08:03 PM
POLAN MARY LAKE PH DDirectorAug 28Sale70.802,358166,93815,179Aug 30 07:59 PM
POLAN MARY LAKE PH DDirectorAug 27Sale70.056,427450,18617,537Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 24Sale70.025,689398,33023,964Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 23Sale70.013,886272,04229,653Aug 27 08:16 PM
POLAN MARY LAKE PH DDirectorAug 20Option Exercise11.9616,002191,38433,539Aug 22 08:02 PM
Abney Michael Donald Jr.SVP - DistributionAug 17Option Exercise15.4017,596270,97826,153Aug 21 08:01 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselAug 17Option Exercise20.1033,550674,23179,931Aug 21 08:02 PM
STEWARD RANDALL JChief Financial OfficerAug 17Option Exercise27.5738,1621,052,12669,952Aug 21 08:04 PM
STEWARD RANDALL JChief Financial OfficerAug 17Sale70.1538,1622,677,07231,790Aug 21 08:04 PM
Bujarski Robert JosephSVP, Bus Dev & Gen CounselAug 17Sale70.1538,5502,704,24841,381Aug 21 08:02 PM
Abney Michael Donald Jr.SVP - DistributionAug 17Sale70.4017,5961,238,8068,721Aug 21 08:01 PM
Brown Thomas DDirectorAug 15Option Exercise15.0815,600235,24869,558Aug 17 07:57 PM
Brown Thomas DDirectorAug 15Sale70.1215,6001,093,87253,958Aug 17 07:57 PM
SLACIK CHARLES PDirectorAug 10Sale68.281,00068,2847,820Aug 14 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 31Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 31Sale67.3612,000808,320294,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 30Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 30Sale65.8412,000790,080294,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 27Option Exercise12.3612,000148,320306,313Jul 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJul 27Sale67.5812,000810,984294,313Jul 31 08:03 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJul 12Option Exercise18.3210,000183,20018,887Jul 13 07:22 PM
Russell Edward KeithS.V.P., N.A. Commercial OpsJul 12Sale68.0910,000680,9388,887Jul 13 07:22 PM
BRYANT DOUGLAS CPresident & CEOJun 29Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 29Sale66.5512,000798,600294,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 28Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 28Sale65.3212,000783,840294,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 27Option Exercise12.3612,000148,320306,313Jun 29 07:55 PM
BRYANT DOUGLAS CPresident & CEOJun 27Sale66.2712,000795,204294,313Jun 29 07:55 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 12Option Exercise25.6423,185594,47436,319Jun 13 07:57 PM
Kroll WernerSVP, R&DJun 12Sale66.162,500165,39216,005Jun 13 08:00 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 12Sale65.0023,1851,507,02513,134Jun 13 07:57 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 11Option Exercise27.573,37092,91116,504Jun 13 07:57 PM
BORKAR RATAN SSVP, Intl Comm OperationsJun 11Sale65.003,370219,05013,134Jun 13 07:57 PM
BRYANT DOUGLAS CPresident & CEOMay 31Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 31Sale62.7112,000752,496294,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 30Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 30Sale62.5712,000750,804294,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 29Option Exercise12.3612,000148,320306,313May 31 08:05 PM
BRYANT DOUGLAS CPresident & CEOMay 29Sale60.9512,000731,400294,313May 31 08:05 PM
Brown Thomas DDirectorMay 25Option Exercise12.5730,451382,83384,409May 25 08:08 PM
Brown Thomas DDirectorMay 25Sale61.3430,4511,867,86453,958May 25 08:08 PM
WIDDER KENNETH JDirectorMay 17Option Exercise0.003,060010,655May 17 08:17 PM
SLACIK CHARLES PDirectorMay 17Option Exercise0.004,20308,820May 17 08:13 PM
POLAN MARY LAKE PH DDirectorMay 17Option Exercise0.003,315023,937May 17 08:10 PM
BUECHLER KENNETH FDirectorMay 17Option Exercise0.007,044048,519May 17 08:07 PM
Brown Thomas DDirectorMay 17Option Exercise0.003,823053,958May 17 08:05 PM
WIDDER KENNETH JDirectorMay 16Option Exercise0.002,01607,595May 17 08:17 PM
Strobeck MatthewDirectorMay 16Option Exercise0.0010803,638May 17 08:15 PM
SLACIK CHARLES PDirectorMay 16Option Exercise0.002,01604,617May 17 08:13 PM
POLAN MARY LAKE PH DDirectorMay 16Option Exercise0.002,016020,622May 17 08:10 PM
BUECHLER KENNETH FDirectorMay 16Option Exercise0.002,328041,475May 17 08:07 PM
Brown Thomas DDirectorMay 16Option Exercise0.002,016050,135May 17 08:05 PM
POLAN MARY LAKE PH DDirectorMay 06Option Exercise0.002,476018,606May 08 08:10 PM
Brown Thomas DDirectorMay 06Option Exercise0.003,094048,119May 08 08:09 PM
BRYANT DOUGLAS CPresident & CEOApr 30Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 30Sale56.6412,000679,656294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 27Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 27Sale56.0212,000672,204294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 26Option Exercise12.3612,000148,320306,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOApr 26Sale55.6112,000667,308294,313Apr 30 08:05 PM
BRYANT DOUGLAS CPresident & CEOMar 29Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 29Sale52.0112,000624,120294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 28Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 28Sale51.3712,000616,464294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 27Option Exercise12.3612,000148,320306,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOMar 27Sale51.5112,000618,156294,313Mar 29 08:04 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 28Sale43.8512,000526,140290,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 27Sale44.4812,000533,772290,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 26Option Exercise12.3612,000148,320302,843Feb 28 08:27 PM
BRYANT DOUGLAS CPresident & CEOFeb 26Sale44.6312,000535,608290,843Feb 28 08:27 PM
BUECHLER KENNETH FDirectorFeb 15Option Exercise16.2512,154197,50339,147Feb 20 08:42 PM
BRYANT DOUGLAS CPresident & CEOJan 31Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 31Sale46.0612,000552,720274,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 30Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 30Sale46.8212,000561,840274,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 29Option Exercise12.3612,000148,320286,493Jan 31 08:03 PM
BRYANT DOUGLAS CPresident & CEOJan 29Sale47.9812,000575,760274,493Jan 31 08:03 PM
SCHULER JACK WDirectorJan 22Sale48.5012,000582,0313,414,053Jan 24 08:20 PM
open in yahoo | open in reuters | open in google